Cargando…
Safety of sildenafil citrate: review of 67 double-blind placebo-controlled trials and the postmarketing safety database
AIM: To review special safety topics associated with sildenafil and to document the tolerability of 50- and 100-mg doses, overall and by age, in men with erectile dysfunction (ED). METHODS: Data were collated from 67 double-blind placebo-controlled (DBPC) trials (> 14,000 men) conducted by the ma...
Autores principales: | Giuliano, F, Jackson, G, Montorsi, F, Martin-Morales, A, Raillard, P |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2810448/ https://www.ncbi.nlm.nih.gov/pubmed/19900167 http://dx.doi.org/10.1111/j.1742-1241.2009.02254.x |
Ejemplares similares
-
Sildenafil citrate as a medical expulsive therapy for distal ureteric stones: A randomised double-blind placebo-controlled study
por: Shokeir, Ahmed A., et al.
Publicado: (2016) -
Intravenous sildenafil citrate and post-cardiac surgery acute kidney injury: a double-blind, randomised, placebo-controlled trial
por: Kumar, Tracy, et al.
Publicado: (2020) -
Long-term safety and effectiveness of sildenafil citrate in men with erectile dysfunction
por: McMurray, James G, et al.
Publicado: (2007) -
Safety and efficacy of sildenafil citrate in reversal of cerebral vasospasm: A feasibility study
por: Mukherjee, Kanchan K., et al.
Publicado: (2012) -
Why sildenafil and sildenafil citrate monohydrate crystals are not stable?
por: Sawatdee, Somchai, et al.
Publicado: (2015)